Navigation Links
Nerites Technology Wins Scientific Accolades
Date:6/23/2008

MADISON, Wis., June 23 /PRNewswire/ -- Anti-fouling medical device coatings developed by Nerites Corporation have received several recent awards recognizing innovation in medical technology. Collaborators at the University of Western Ontario and the Lawson Health Research Institute tested urinary stents coated with Nerites' polymers, and demonstrated a significant reduction in animal infection levels.

Unlike active antibiotic-releasing coatings, which cannot protect against resistant bacterial strains, the Nerites technology passively prevents bacteria from attaching to the medical device and forming an infectious biofilm. In this way, the passive coating may have both greater efficacy and fewer side effects than active coatings. Recognition for this work includes:

-- First place in the New Investigator Competition at the 2008 Society for Infection and Inflammation in Urology Annual Meeting

-- Top Research Poster at the 61st Annual Meeting of The Urological Society of Australia and New Zealand

-- First place in the Basic Science Division at the 2007 Endourological Society Fellowship Essay Competition

-- Publication in the Journal of Endourology in June, 2008

The research was led by Peter Cadieux and Hassan Razvi, of the University of Western Ontario, and Raymond Ko, of the University of Sydney. "Urinary conditioning films that form on medical devices are notorious for covering up the effects of existing coatings, augmenting bacterial attachment and providing nutrients to the microbes," stated Cadieux. "By preventing the attachment of both bacteria and urine, the Nerites' coatings demonstrate great promise for preventing biofilm formation and related infections."

"We're really pleased to have our coatings technology validated by our academic partners and their peers in medical research," stated CEO Tom Mozer, "we hope that corporate partners will also be interested in bringing this innovation to the millions of patients who may suffer from device-related infections."

About Nerites: Nerites Corporation develops fully-synthetic, water-resistant adhesives, sealants, and coatings for internal medical use. The hydrogel technology can be used to close internal tears or incisions, to seal tissues and prevent leakage and infection, and to affix synthetic or biologic medical devices. Properties can be "tuned" to fit each application. The technology was described with a cover article in the journal Nature (July, 2007) and was labeled "one of the top 100 scientific developments of 2007" by Discover Magazine. (http://www.Nerites.com)


'/>"/>
SOURCE Nerites Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Nerites Corporation Announces Closing of Series A Funding Round
2. Nerites Receives NIH Grant to Study Novel Treatment for Preventing Dangerous Bacterial Infections on Urinary Stents and Catheters
3. ONR offers up to $1M for innovative science and technology ideas
4. Revolutionary Therapy: Needle-Free Technology for the Treatment Of Blinding Eye Disease
5. Plexus Online Enables Business-Government-Academic Collaboration for Advanced Technology Institute
6. China Sky One Medical, Inc. Research Center Recognized by Heilongjiang Science and Technology Institute
7. Shanghai Medical Technology Co., First Quarter 2008 Financial Results
8. Micromagnets May One Day Enhance MRI Technology
9. SAND Technology Appoints Zainab Ahmed Schwartz as CFO
10. Pop! Technology Goes Growthink
11. Medicsight ColonCAD Technology Successfully Identified Cancer in 100% of Patients Included in Data Presented at ESGAR 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... More than a third of American adults are considered ... surgery has received increased attention in recent years, as an article published ... weight loss, most people are familiar with the basic requirements of maintaining a healthy ...
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/26/2016)... ... ... There are many ways to cook a hot dog, but new research commissioned ... dogs straight off the grill. Of the 90 percent of Americans who say they ... hot dog, far outpacing other cooking methods such as steaming (12 percent), microwaving (9 ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Connor Sports, ... basketball as a partner for the Tamika Catchings Legacy Tour that will ... industry leader in hardwood basketball surfaces in all forms and levels of the game, ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... MedDay, a biotechnology company focused on the treatment ... "High doses of biotin in progressive multiple sclerosis: extension phase ... Ayman Tourbah , Principal Investigator of the Phase 3 ... Neurology (EAN) in Copenhagen, Denmark . The ... on Sunday, 29 May 2016 from 14:45 to 16:15 CEST ...
(Date:5/24/2016)... --   , ... Endpunkte und demonstriert Ebenbürtigkeit bei der Gesamtreinigung des ... guter , Reinigung des ... (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) , ... der MORA-Studie der Phase III für NER1006 (1 ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
Breaking Medicine Technology: